TEEBACIN Drug Patent Profile
✉ Email this page to a colleague
When do Teebacin patents expire, and what generic alternatives are available?
Teebacin is a drug marketed by Consolidated Midland and is included in one NDA.
The generic ingredient in TEEBACIN is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEEBACIN?
- What are the global sales for TEEBACIN?
- What is Average Wholesale Price for TEEBACIN?
Summary for TEEBACIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Patent Applications: | 6 |
| DailyMed Link: | TEEBACIN at DailyMed |
US Patents and Regulatory Information for TEEBACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Midland | TEEBACIN | aminosalicylate sodium | TABLET;ORAL | 007320-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
